Integrated multi-omics reveals the ITGB2-IL2RB-NK axis in promoting papillary thyroid carcinoma progression and immune microenvironment crosstalk

整合多组学分析揭示了ITGB2-IL2RB-NK轴在促进乳头状甲状腺癌进展和免疫微环境相互作用中的作用

阅读:1

Abstract

INTRODUCTION: Papillary thyroid carcinoma (PTC) is the most common thyroid malignancy, with some cases exhibiting aggressive features and therapeutic resistance. Dysregulated protein interaction networks and remodeling of the immune microenvironment have been increasingly recognized as critical in PTC progression. However, the genetic, protein, and immune regulatory networks involved in PTC have yet to be systematically elucidated. To address this gap, we employed an integrated multi-omics and genetic epidemiological approach. METHODOLOGY: This study employed a multi-stage integrated analysis strategy combining Mendelian randomization (MR), mediation analysis, and bioinformatics validation. First, MR was applied using protein quantitative trait loci (pQTL) data from the deCODE and UK Biobank Pharma Proteomics Project (UKB-PPP) databases, together with PTC genome-wide association study (GWAS) data from FinnGen, to screen for PTC-associated proteins. Second, a two-step mediation analysis was conducted to construct protein–protein interaction (PPI) networks and immune microenvironment regulatory networks. Finally, differential expression and co-expression analyses were performed using The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) databases to validate the functional relevance of the identified networks. RESULTS: We identified the ITGB2 (integrin β2)-IL2RB (interleukin-2 receptor β)-natural killer (NK) cell regulatory axis, which was significantly associated with PTC risk. This regulatory axis exhibited marked differential expression and co-expression relationships in PTC tissues, confirming its functional relevance. CONCLUSION: This study establishes a causal regulatory chain of "ITGB2-IL2RB-NK cell" in PTC through integrated multi-omics and genetic epidemiological approaches. This work provides a theoretical basis for developing combined immunotherapy strategies targeting components of the ITGB2-IL2RB-NK cell regulatory axis within the tumor microenvironment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12672-026-04446-x.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。